Suggestions
Benjamin Schrank
Resident Physician at Memorial Sloan Kettering Cancer Center
Professional Background
Dr. Benjamin Schrank is a highly accomplished physician specializing in the field of oncology. Currently serving as a resident physician at the prestigious Memorial Sloan Kettering Cancer Center in New York, NY, Dr. Schrank is positioned at the forefront of cancer treatment and research. With an upcoming residency in the Department of Radiation Oncology at the renowned UT MD Anderson Cancer Center, Dr. Schrank continues to advance his expertise in cancer therapy, making significant strides in the medical community.
Dr. Schrank's professional journey is underscored by a robust academic foundation and hands-on research experience. He combines clinical practice with cutting-edge investigative research, focusing on the complexities of cancer genomics, particularly in the areas of genome instability and its implications for therapeutic resistance.
Education and Achievements
Dr. Schrank's educational pedigree is impressive and indicative of his dedication to the medical sciences. He earned his Doctor of Medicine (M.D.) degree from the Columbia University College of Physicians and Surgeons, where he also pursued a Doctor of Philosophy (Ph.D.) in Genetics at the Columbia University Graduate School of Arts and Sciences, demonstrating his commitment to intertwining clinical practice with rigorous research.
His undergraduate education at Brown University culminated in a Bachelor of Science (Sc.B.) in Neuroscience, where he graduated with honors, showcasing his early inclination towards understanding complex biological systems. To further bolster his academic experience, Dr. Schrank has also studied Neuroscience at the University of Oxford, further enriching his understanding of the neurological underpinnings associated with medical conditions.
Notably, during his Ph.D. work, Dr. Schrank centered his research on the DNA double-strand breaks' movement and repair, contributing valuable insights into genetics. His work was published in the eminent journal Nature, underscoring the significant impact of his research within the scientific community. Furthermore, he received the prestigious Titus Munson Coan Prize for excellence in translational biology research, highlighting his contributions to advancing cancer treatment methodologies.
Notable Research Experience
Dr. Schrank's professional background is complemented by a diverse array of research positions that have equipped him with unique insights into the molecular mechanisms of diseases. Prior to his residency, he served as an MD/PhD candidate at Columbia University Vagelos College of Physicians and Surgeons, where he honed his skills in translational medicine, bridging the gap between research and clinical application.
He has also held research positions at several prominent institutions, including Massachusetts General Hospital, where he gained invaluable hands-on experience as a Research Technician, developing a comprehensive understanding of laboratory practices and processes. His tenure as a Research Assistant at both Brown University and the BloodCenter of Wisconsin allowed him to explore various facets of neuroscience and blood disorders, shaping his approach to clinical and research domains.
Research Interests
Dr. Schrank's primary research interests lie in the intricacies of cancer biology, particularly how single-cell genomics can elucidate mechanisms of clonal evolution and cancer resistance to therapies. In an era where personalized medicine is paramount, his focus on understanding genome instability is particularly noteworthy. His work aims to spearhead innovations that can transform cancer therapeutics and improve patient outcomes, solidifying his role as a vital contributor to the ongoing battles against cancer.
Dr. Schrank’s tenacity and commitment to unraveling the complexities of cancer genetics underscore his standing as a future leader in the medical community. His ongoing work at Memorial Sloan Kettering Cancer Center and his future residency at UT MD Anderson Cancer Center position him to influence the next generation of cancer treatment paradigms significantly.